Metraipolis › archive › dc_dc9cee4faad2

Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases — Europe PMC PMID:41640346

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41640346
DOI: 10.1002/sim.70409
License (as archived): solo-consultazione
Archived: 2026-11-06T08:47:22.562Z
SHA-256 of the archived text: 57d56d3cda02d3de1ac9044572b6b2d020893f6cd5290971fcd7f5344df7aa28
Stable URL of this page: https://metraipolis.com/documento/dc_dc9cee4faad2

How to cite

Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases — Europe PMC PMID:41640346 — Europe PMC (en), https://europepmc.org/article/MED/41640346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc9cee4faad2 (Metraipolis archive dc_dc9cee4faad2, sha256 57d56d3cda02d3de1ac9044572b6b2d020893f6cd5290971fcd7f5344df7aa28)

BibTeX

@misc{dcdc9cee4faad2,
  title = {Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases — Europe PMC PMID:41640346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41640346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc9cee4faad2; sha256 57d56d3cda02d3de1ac9044572b6b2d020893f6cd5290971fcd7f5344df7aa28},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41640346. Agents can read the archived copy with the MCP tool read_document.